Artificial intelligence is moving into every major industry.

Companies are using AI to improve healthcare, automate finance, power marketing tools, and build new products at a pace that was not possible a few years ago. This speed creates opportunity, but it also creates legal risk.

Many AI companies focus on product development, hiring engineers, and raising capital. Legal planning often comes later. That delay can lead to problems once a company starts scaling, signing customers, or attracting regulatory attention.

AI companies that address legal issues early tend to grow with fewer disruptions. They are also more attractive to investors, partners, and enterprise customers.

This guide explains the key legal issues AI companies should understand and address as they build and scale their businesses.

Data Privacy and Data Collection

Every AI system depends on data. That makes data governance one of the first legal issues a company must address.

If a company collects or uses data in a way that violates privacy laws, it can face regulatory action, fines, and loss of trust. These risks can arise even if the company does not intend to misuse data.

AI companies should focus on how data moves through their systems. This includes how data is collected, stored, processed, and used in training.

Several laws may apply depending on where users are located and what type of data is involved. These include the California Consumer Privacy Act, the General Data Protection Regulation in Europe, and state biometric privacy laws such as Illinois BIPA.

A common mistake is assuming that publicly available data is safe to use. That is not always true. Data can still be protected by privacy or intellectual property laws even if it is accessible online.

AI companies should review:

  • where their training data comes from
  • whether they have the right to use it
  • how long they retain it
  • what disclosures they provide to users

Clear documentation is critical. If a company cannot explain its data practices, it will struggle to defend them.

Intellectual Property and Ownership

Intellectual property issues sit at the center of AI law.

AI companies need to understand both how they use other people’s content and how they protect their own systems.

One of the main questions involves training data. Many AI models are trained on large datasets that include text, images, or code from public sources. The fact that content is publicly available does not mean it is free to use. Copyright owners have already filed lawsuits that focus on this issue.

Another challenge involves ownership of AI-generated content. Businesses need to decide how rights are allocated between the company and the user. If a platform generates text, images, or code, the terms of service should clearly state who owns that output and what rights the user receives.

There is also the risk that AI outputs may infringe on third-party intellectual property. For example, a model could generate content that is similar to copyrighted material. Companies should consider how to manage that risk through both technical controls and contractual terms.

At the same time, AI companies need to protect their own assets. This includes model architecture, training datasets, and internal processes. Most companies rely on a mix of trade secrets, contracts, and limited patent protection. Without these protections, it can be difficult to maintain a competitive edge.

Liability and Product Risk

AI systems can produce outputs that affect real people. When those outputs are wrong, companies can face legal claims.

The type of risk depends on how the AI is used. A tool that generates marketing copy carries less risk than a tool that provides medical or financial guidance. However, even lower-risk applications can create problems if users rely on them in unexpected ways.

Courts may evaluate AI-related harm under existing legal theories. These include negligence, product liability, misrepresentation, and consumer protection laws. The law in this area is still developing, but companies should not assume they are protected simply because the technology is new.

To reduce risk, AI companies should focus on how they present their products. Clear limitations on use, strong disclaimers, and accurate descriptions of what the system can and cannot do all help set expectations.

Contracts also play a key role. Terms of service should define how the product may be used and limit liability where possible. While these terms cannot eliminate all risk, they can reduce exposure and provide a stronger defense.

Bias, Discrimination, and Fairness

AI systems learn from data. If that data contains bias, the system may reproduce it.

This has already led to legal and regulatory attention in areas such as hiring, lending, insurance, and criminal justice. In these contexts, biased outputs can lead to claims of discrimination or unfair treatment.

Regulators are increasingly focused on how automated systems affect protected groups. Even if a company does not intend to discriminate, it may still face liability if its system produces a disparate impact.

AI companies should take steps to identify and address bias early. This often includes testing models, reviewing training data, and documenting decisions made during development.

These practices are not only useful for compliance. They also help build trust with customers and partners.

AI Regulation Is Expanding

Governments are working to define how AI should be regulated.

In the European Union, the AI Act introduces a risk-based framework that classifies systems based on how they are used. Higher-risk systems face stricter requirements.

In the United States, there is no single federal AI law. However, regulators are already applying existing laws to AI companies. The Federal Trade Commission has made it clear that it will use its authority to address unfair or deceptive practices involving AI.

States are also developing their own rules. Some focus on transparency, while others address automated decision making and consumer rights.

AI companies should not wait for a complete legal framework. The current environment already requires compliance with multiple overlapping laws.

Open Source and Licensing

Many AI systems rely on open-source software. This can speed up development, but it also creates legal obligations.

Open-source licenses often include conditions that companies must follow. Some require attribution. Others limit commercial use. Certain licenses may require a company to release its own code if it incorporates open-source components in a specific way.

Failure to comply with these terms can lead to disputes or force a company to change its product.

AI companies should track the open-source components they use and understand the terms attached to each one. Regular audits can help identify issues before they become serious problems.

Transparency and Disclosure

Regulators are placing more emphasis on transparency in AI systems.

Companies may need to disclose when users are interacting with AI or when content is generated by a machine. This is especially important in areas where users might assume they are dealing with a human or receiving professional advice.

Examples include chatbots, synthetic media, and automated decision tools.

Clear disclosure helps reduce the risk of misleading users. It also aligns with broader consumer protection principles that apply across industries.

AI in Regulated Industries

AI companies that operate in regulated sectors face additional challenges.

In healthcare, AI tools used for diagnosis or treatment may be regulated as medical devices. In financial services, AI systems must comply with lending laws, securities regulations, and other rules that govern financial advice.

In life sciences, AI used in drug development or clinical decision support may trigger oversight from the FDA.

These industries have existing regulatory frameworks that apply regardless of whether AI is involved. Companies need to understand how those frameworks interact with their technology.

Platform and Distribution Rules

AI companies that distribute products through apps or online platforms must also follow platform rules.

Apple and Google have their own guidelines that govern what apps can do and how they handle user data. Platforms often apply stricter standards to apps that involve health, finance, or user-generated content.

Failure to comply with these rules can lead to delays, rejection, or removal from the platform.

Companies should review platform policies early in development rather than treating them as an afterthought.

Contracts and Risk Allocation

Contracts are one of the most effective tools for managing AI risk.

A well-drafted agreement helps define the relationship between the company and its users. It sets expectations and limits exposure.

Important provisions often include:

  • limits on how the product can be used
  • disclaimers about AI outputs
  • limits on liability
  • ownership of data and outputs
  • restrictions on misuse

These terms should reflect how the product actually works. Generic agreements may not address the specific risks associated with AI systems.

Frequently Asked Questions About AI Legal Risks

What are the biggest legal risks for AI companies?

The most common risks involve data privacy, intellectual property, liability for outputs, and compliance with existing laws that apply to how AI is used.

Can AI companies use publicly available data?

Not always. Public access does not remove legal protections. Companies still need to consider copyright, privacy, and terms of use.

Who owns AI-generated content?

Ownership depends on the company’s terms and how the system is structured. This should be clearly defined in user agreements.

Are AI companies regulated in the United States?

Yes. Existing laws such as consumer protection and anti-discrimination rules already apply, even without a single federal AI statute.

Do AI startups need legal counsel early?

Yes. Addressing legal issues early is often more efficient than fixing problems after a product is launched or scaled.

How LumaLex Law Helps AI Technology Companies

AI companies operate in a fast-moving environment where legal rules are still developing. That creates uncertainty, especially as companies begin to scale, raise capital, or enter regulated markets.

LumaLex Law works with AI companies at different stages of growth to help address these challenges early.

This often includes:

  • reviewing data collection and privacy practices
  • structuring intellectual property ownership and protection
  • drafting terms of service and user agreements
  • evaluating regulatory risk across different jurisdictions
  • advising on compliance for healthcare, financial, and other regulated applications

Legal planning is most effective when it is built into the product and business model from the start. Addressing these issues early can help avoid costly changes later.

What AI Companies Should Do Next

AI companies do not need to solve every legal issue at once. However, they should take a structured approach.

A practical starting point includes:

  • mapping out how data is collected and used
  • reviewing terms of service and customer agreements
  • identifying areas where the product could create liability risk
  • evaluating whether the product touches regulated industries
  • documenting internal policies and development decisions

Even a basic review can help identify gaps before they become larger problems.

Companies that take these steps early are often in a stronger position when working with investors, enterprise clients, and regulators.

Talk With LumaLex Law

Artificial intelligence is changing how businesses operate. The legal landscape is evolving alongside it.

Companies that understand their legal obligations are better positioned to grow, build trust, and avoid disruption.

If your company is developing or deploying AI technology and you want guidance on legal risk, compliance, or structuring, LumaLex Law can help you evaluate your position and plan next steps.

Contact LumaLex Law to schedule a confidential consultation.

This article is for informational purposes only and does not constitute legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Ian Horowitz

Ian Horowitz

Of-Counsel
States Licensed: FL

Mr. Horowitz focuses his practice on estate planning, taxation, and business related matters, with advanced proficiency in estate, gift, federal income, and generation-skipping transfer taxation. His extensive knowledge in these areas enables him to craft tailored strategies that optimize tax efficiency and safeguard his clients’ assets. From crafting straightforward wills to designing complex domestic and foreign trusts, his commitment to preserving wealth and ensuring asset protection is unwavering.

In addition to his prowess in estate planning, Mr. Horowitz serves as a trusted advisor to businesses of all sizes from formation to sale assisting with drafting purchase and sale agreements, limited liability operating agreements, or other corporate documents. His counsel on entity formation and tax-efficient structures empowers entrepreneurs and corporations to make informed decisions that drive growth and prosperity.

Mr. Horowitz possesses a wealth of experience in international tax matters. He offers invaluable guidance to foreign clients navigating inbound business and real estate transactions in the United States. He is also recognized for his efficiency in helping individuals become bona fide residents of Puerto Rico under IRC Section 937. This specialized knowledge in tax strategies related to Puerto Rico’s unique tax laws positions him as a sought-after advisor for those seeking to take advantage of the favorable tax incentives offered by Puerto Rico.

Aggeliki Psonis

Aggeliki Psonis

Associate
States Licensed: NY, NJ. MA

A graduate of Boston University, with a JD from CUNY law school, Aggeliki focuses her practice on real estate transactions, estate planning and administration, business law and general litigation. She has extensive experience representing buyers, sellers, investors and business owners based in New York and internationally.

Aggeliki is admitted in the states of New York, New Jersey and Massachusetts, as well as in the Eastern and Southern Districts of New York. She is also a licensed Real Estate broker. She is a proud member of the Inspiring Women in Law League (IWILL) and the Hellenic Lawyers Association. She speaks fluent Greek and conversational French and Spanish. Aside from lawyering, she enjoys being a radio producer and performing artist.

Dallas Robinson, Of-Counsel

Dallas Robinson

Of-Counsel
States Licensed: FL

 

Dallas Robinson is an AV Preeminent-rated trial attorney who has dedicated his practice to representing injured people throughout Florida. Dallas has litigated and tried many different types of personal injury cases in numerous courthouses and venues in Florida. Dallas believes in prosecuting personal injury cases in a professional and aggressive manner, and has a clear track record of success in obtaining great financial compensation for his clients either through verdicts or settlements. Many lawyers advertise ‘trial experience,’ but have actually never seen the inside of a courtroom. Dallas has spent his entire career in the courtroom and litigating cases. This gives Dallas the real and true experience that it takes to strike fear in the hearts of insurance companies and obtain top financial compensation for his injured clients.

 

Dallas grew up in South Florida and attended Boston University where he played quarterback and defensive back for Boston University’s football team. Dallas graduated in 4 years with bachelor degrees in Classical Civilizations and History. He went straight to law school and attended University of Miami (FL) School of Law. Dallas graduated in 2002 with a Juris Doctorate degree and immediately passed the Florida Bar.

 

Dallas began his legal career representing businesses and insurance companies in workers’ compensation and personal injury cases. This gave him unique insight into exactly how insurance companies work and how they value cases. After achieving a high level of success in litigating these cases, Dallas moved on to representing the injured. Since that time, Dallas has obtained tens of millions of dollars in compensation for his clients through settlements and trial verdicts. Dallas is a member of the Multi-Million Dollar Advocates Forum which is an association of attorneys who have won seven-figure verdicts and settlements on behalf of their clients. This group is one of the most prestigious organizations for trial lawyers in the United States as fewer than 1% of U.S. lawyers have qualified as members.

 

In addition to great results for his clients, Dallas has also gained the respect of his peers for his ethics, ability, and professionalism. Dallas has received the highest level of distinction of an AV ® rated attorney by Martindale-Hubbell, which recognizes Dallas as possessing “Very High-Preeminent” legal ability with “Very High” ethical standards.

Yisroel Szpigiel, Of-Counsel

Yisroel Szpigiel

Of-Counsel States Licensed: NY, NJ  
Yisroel Szpigiel is a NY/NJ corporate attorney focused on outside general counsel and commercial transactions. With nearly a decade of experience managing law firms, he represents entrepreneurs, investors, and some of New York’s largest real estate developers in matters ranging across the full business lifecycle– from entity formation and early stage growth to day-to-day commercial contracting to complex financings, acquisitions, and strategic exits. He has closed over $100 million in transactions and is known for practical, business-first legal guidance that protects clients while keeping deals moving. 
 
Since joining LumaLex Law as Managing Partner January 2025, Yisroel has grown the firms Commercial Transactional and Real Estate Practices, and has started the firms MSO practice, focusing on private equity healthcare rollups. Yisroel is best known as a “problem solver”, with the ability to turn complex problems into workable solutions. He was twice named as a Super Lawyers New York Rising Star in 2024 and 2025, in the practice areas of Business Law, Real Estate, Mergers and Acquisitions, and Plaintiff’s Personal Injury.

In addition to his work with LumaLex Law and serving as trusted outside counsel to businesses in a wide range of industries, he has been recognized by community leaders with citations and awards. Yisroel earned his undergraduate degree from Rutgers University and his J.D. from Hofstra University School of Law, where he later returned as an adjunct professor. Outside the office, he enjoys golf, pickleball, and traveling with his wife and three children. 
Tom Dean | Of-Counsel

Tom Dean

Of-Counsel 
States Licensed: AZ

 

Tom Dean has been an attorney advocate for nationwide cannabis policy reform for over 25 years. As Legal Director for the National Organization for the Reform of Marijuana Laws (NORML) he initiated, managed, and litigated important cannabis related cases of national importance to the cannabis industry/community. In that capacity, he also coordinated the efforts of the NORML Legal Committee (lifetime member) and NORML Amicus Committee (former chair) in key cases throughout the U.S.  In 2015 the organization recognized his successful advocacy by inducting him into the NORML Distinguished Counsel’s Circle. He remains an active member of the NORML Legal Committee.

In 2016, Tom received the President’s Commendation award from the Arizona Attorneys for Criminal Justice (AACJ). In 2020, Tom received a Lifetime Achievement Award from the Errl Cup, a medical marijuana event producer which includes Arizona’s premier cannabis awards festival (30,000 attendees this year).

In 2021, Tom received Mikel Weiser Lifetime Achievement Award from Arizona’s Marijuana Industry Trade Association (MITA). Most recently, in 2023, Tom was honored by NORML with its Al Horn Award, which the organization awards to an attorney each year to in “recognition of a lifetime of ceaseless work to advance the cause of justice” in cannabis law.

Tom was a founding member of the Arizona Cannabis Bar Association (ACBA), an organization that seeks to educate lawyers and the public of the many unique aspects of cannabis law and emerging cannabis related areas of practice. He continues to serve on the board of ACBA. Outside of his practice, Tom enjoys, among other things, presenting at cannabis related seminars and conferences for lawyers and the public.

Josh Sanderlin | Of Counsel

Joshua Sanderlin

Of Counsel
States Licensed: MD, D.C.

Joshua Sanderlin is an experienced cannabis attorney and government affairs expert barred in Maryland and the District of Columbia. He has worked in the cannabis industry since 2013. At that time, he was an attorney and lobbyist at a large, global law firm. His experience working with clients in the earliest legal cannabis market in the U.S. sparked his interest in the field and motivated him to leave big law for the world of cannabis.

Since then, he has served as a lawyer and consultant to clients working in markets across the country, including seven states and the District of Columbia. His experience has given him a wide breadth of knowledge on issues touching the industry and, just as importantly, expanded his network to include experts from all across the industry. Having worked on cannabis issues in a variety of settings, Joshua understands that the industry is best served by specialized services.

Edgar J. Asebey | Of Counsel

Edgar J. Asebey

Of Counsel
States Licensed: FL, D.C.

 

Edgar J. Asebey is a regulatory and transactional attorney with over two decades of experience in federal regulation of pharmaceutical, biotechnology, medical device, food, dietary supplement and cosmetics companies. Since 2015, he has been working on Cannabis-related matters and transactions and since 2018 he has provide regulatory compliance, business transactional, venture finance and international trade services to hemp/CBD companies. Edgar brings a wealth of knowledge and over 20 years of experience to life science, Cannabis and hemp/CBD clients who require novel solutions to complex issues.

Edgar practices before the Food and Drug Administration (FDA), United States Department of Agriculture (USDA), Customs and Border Protection (CBP), Environmental Protection Agency (EPA), and the Federal Trade Commission (FTC), representing client companies on regulatory compliance, product approval/registration and FDA enforcement defense matters. He also assists clients with international and domestic business transactions, IP licensing, venture finance, trademark protection and import/export matters.

Edgar studied molecular biology at the University of Chicago and spent 5 years working in molecular biology research laboratories at the University of Chicago and the University of Illinois.  Early in his career he served as a Patent and Licensing Advisor to the Natural Products Branch of the National Cancer Institute at the National Institutes of Health (NIH).  He founded and served as president of Andes Pharmaceuticals, Inc., a natural products drug discovery company, from 1994 to 2000 and has served as in-house counsel to two life sciences companies. Most recently he was an equity partner in the Health Care & Life Sciences Practice Group at Jones Day. Edgar is currently a partner at Keller Asebey Life Science Law, PLLC.

While Edgar holds licenses to practice law in Florida and Washington, D.C. he can represent clients on federal regulatory matters in all 50 states.  He is a member of the American Bar Association (Section on Administrative Law & Regulatory Practice: Food and Drug Committee and International Committee), Food & Drug Law Institute (FDLI), Dade County Bar Association, and BioFlorida.

Dan Miller Head-Shot | Of-Counsel

Dan Miller

Of-Counsel
States Licensed: CA

Dan Miller, Esq., with over 15 years of experience in cannabis law and a growing expertise in psychedelics, is a staunch advocate for honoring both traditional and evolving regulated uses of these substances. A Vermont Law School alumnus (Class of 1998), he holds a J.D. and a Master’s in Environmental Law and Policy.

Before his foray into the world of entheogenic medicines, Dan honed his skills as a trial attorney with a focus on both criminal and civil cases. His passion for and in-depth understanding of cannabis and psychedelic substances redirected his career path, leading him to develop a niche practice area that has since become his hallmark.

Dan’s role in the cannabis industry is not just as a lawyer, but as a partner in his clients’ endeavors. He oversees all aspects of business development, from structural planning and licensing to adapting to dynamic legal landscapes. His strategic insights have been key in securing licenses, operational planning, and facilitating interstate business growth.

Dan continues to serve as outside general counsel for various businesses, leveraging his litigation background to offer comprehensive legal advice.

As the legal landscape continues to evolve, Dan Miller remains a steadfast and knowledgeable advocate, committed to bridging the gap between traditional use and modern regulatory frameworks in the world of cannabis and psychedelics.

States Licensed: CA

Christina Jaramillo | Junior Associate

Christina Jaramillo

Junior Associate
States Licensed: FL, CA

Christina Jaramillo is an Associate Attorney at LumaLex Law and an active member of The Florida Bar. Christina’s primary focus has been in the practice area of business transactions. Christina has legal experience drafting and reviewing various sales and services agreements, completing entity filings and EIN applications, drafting corporate governance documents and business plans, preparing franchise disclosure documents, drafting and reviewing commercial and residential lease agreements, assisting with mergers and acquisitions, preparing demand letters, working on estate plans and probate matters, and trademarks. Prior to joining LumaLex Law, Christina led the estate planning department at The Law For All, P.A.

Christina is the daughter of two Latinx immigrants, the youngest of five siblings, and the first member of her immediate family to graduate from college. In 2017, after just three short years on campus, Christina received her Bachelor of Science in Political Science, magna cum laude, from Florida State University, where she also minored in Economics. Christina received her Juris Doctor, magna cum laude, from the University of Miami School of Law in 2020.

While attending the University of Miami School of Law, Christina received several honors: Christina was nominated to serve as one of two Articles & Comments Editors for the University of Miami International and Comparative Law Review; Christina was a recipient of the Dean’s Certificate of Achievement Award, which is awarded to the top one or two students in the course, in Legal Communications & Research II; and Christina made the Dean’s List twice.

During her time in law school, Christina served as a Fellow and Blog Editor for the Professional Responsibility and Ethics Program (PREP), an intern for the Human Rights Clinic, and a Civil Procedure Dean’s Fellow. Christina was active on campus and engaged in her community because she understood the value in connecting with those around her and serving the needs of her community, which remains true today.

In her free time, Christina can be found at her local comic book shop or vegan bakery. Christina loves to read, stay up to date on popular television shows and movies, watch soccer, and occasionally jog.

Andy Sick | Partner

Andy Sick

Partner
States Licensed: NY, NJ, MI, CT

Andy Sick has been advising businesses, startups, and entrepreneurs for nearly 15 years. He assists clients through every stage of the business life cycle from incorporation and initial growth phases, to maturity with ongoing general counsel services including regulatory compliance and critical commercial transactions, and dissolution. Licensed to practice in New York, New Jersey, and Connecticut, Andy is the attorney responsible for the firm’s practice in these states.

At Mr. Cannabis Law, Andy represents various cannabis-related businesses on such matters as corporate structuring, licensing, and financing. He navigates clients through the constantly changing sea of cannabis rules and regulations. Andy handles marijuana license applications, business plans, and operating procedures for dispensaries, cultivators, nurseries, manufacturers, distributors, wholesalers, delivery services, and testing facilities. For the firm’s hemp industry clients, Andy helps obtain hemp licenses and maintain compliance with federal and state regulations. In the psychedelic space, Andy has served as a legal advisor to numerous non-profits, companies, and organizations including such groups as Decriminalize Nature and the Native American Church.

Andy began his legal career at boutique law firms serving as outside general counsel to businesses and representing clients in complex commercial litigation. Whether representing a three-person video game startup or a multinational spent nuclear fuel storage company, Andy worked directly with company presidents and other executives to develop and implement corporate legal strategies. Subsequently, he founded several startups, including a legal technology company that adapted artificial intelligence and virtual reality for use in the law. In addition to working with Mr. Cannabis Law, Andy has his own law firm, Sick Legal, which provides business and commercial transactional services to a range of clients.

During law school, Andy worked at the U.S. Justice Department’s Office of Consumer Litigation, the U.S. Attorney’s Office for the Northern District of New York, and for President Joe Biden when he served on the U.S. Senate Judiciary Committee

Andy is responsible for firm operations in New York, New Jersey, Michigan, and Connecticut 

Amanda Barton | Partner

Amanda Barton

Partner
States Licensed: FL

Amanda Barton is an active member of the Florida Bar and is admitted to practice in all U.S. District Courts and U.S. Bankruptcy Courts within the state of Florida.  Amanda has over ten years of legal experience handling complex corporate matters, with a strong focus on corporate governance, corporate finance, and regulatory compliance.  As someone who loves written language, Amanda excels in drafting and negotiating a vast array of legal documents.

Prior to joining LumaLex Law, Amanda had unique legal opportunities that have made her a well-versed, seasoned transactional business attorney.  Previously, she led the transactional department at The Law for All, P.A., where she assisted business clients with strategic business structuring, mergers and acquisitions, asset protection, business succession planning, and contract drafting, including companies involved in the cannabis and hemp industry.  She served as senior in-house counsel for an alternative financing company, where she built a legal department that leveraged technology, data analysis, and innovative resolution and recovery strategies.  Amanda also served as in-house counsel to a private investment firm, where she handled all in-house transactions with a concentration in Debtor-in-Possession financing for Chapter 11 debtors, secured lending transactions, fund management, and various aspects of municipal bond financing.

Amanda currently volunteers her time to serve as the President of the Broward County chapter of CannabisLAB, a networking and education group for professionals who are in or are looking to get involved in the cannabis marketplace.

Dustin Robinson | Managing Partner

DUSTIN ROBINSON

Founding Partner
States Licensed: FL

Dustin Robinson is the Founding Partner of LumaLex Law. Licensed in Florida as an Attorney, Certified Public Accountant, and Real Estate Agent, Robinson brings a rare, fully integrated legal–financial–business perspective to every engagement. His practice focuses on corporate structuring, regulatory strategy, transactions, capital formation, and high-stakes commercial litigation for growth-stage and emerging-market companies across a wide range of industries.

Before launching LumaLex Law, Robinson trained at two of the world’s most respected professional services firms—Deloitte and Holland & Knight—where he developed deep technical grounding in tax, corporate law, and complex commercial matters. He then left traditional practice to become an operator himself, applying his legal and accounting background to help run a multi-state manufacturing company that he helped grow to nearly $50 million in revenue. That experience shaped his core philosophy: great legal advice must be practical, entrepreneurial, and grounded in the realities of building and scaling real businesses.

Robinson is not only an advisor to entrepreneurs—he is one. In addition to LumaLex Law, he is the founder of multiple ventures, including Iter Investments , a venture capital fund backing frontier technologies and next-generation healthcare platforms; and Nucleus, a venture studio focused on launching digital and data-driven assets in emerging markets. Across his legal and investment platforms, Robinson has worked with founders operating in biotech, neurotech, telehealth, psychedelics, cannabis, fintech, real estate, digital media, AI-driven platforms, and other highly regulated or rapidly evolving sectors.

Widely regarded as a trailblazer in emerging industries, Robinson has played a leading role in shaping legal and commercial frameworks for novel business models long before they became mainstream. He has served as lead counsel in several high-profile commercial disputes, including the widely covered Shohei Ohtani 50–50 baseball litigation, and is frequently sought out for matters involving regulatory gray zones, innovative deal structures, and first-of-their-kind ventures.

Robinson also served on the Board of Directors of Clairvoyant Therapeutics, a biotechnology company that was advancing psilocybin-based treatments for alcohol use disorder through FDA clinical trials. He has advised and represented numerous venture-backed companies, founders, and investment vehicles operating at the intersection of science, technology, regulation, and capital markets.

Beyond legal practice and investing, Robinson is deeply involved in thought leadership and ecosystem-building. He created and moderates a long-running monthly panel series at Soho Beach House Miami, convening founders, physicians, scientists, investors, and cultural leaders to discuss innovation, wellness, and frontier technologies. Past guests have included NBA Champion Lamar Odom, NHL star Daniel Carcillo, and other prominent figures across business and entertainment.

Robinson has been regularly profiled and featured as an expert in major media outlets, including Bloomberg News, Forbes, The Wall Street Journal, INSIDER, VICE, The Miami Herald, Authority Magazine, Thrive Global, Benzinga, and others. He is a frequent speaker at global industry conferences and private founder and investor forums.

A triple Gator, Robinson earned his Bachelor’s in Accounting, Master’s in Accounting, and Juris Doctor from the University of Florida.

Today, Robinson’s work sits at the intersection of law, entrepreneurship, and capital formation. He is known for helping founders think bigger, structure smarter, and move faster—while staying compliant, investable, and defensible. His mission is simple: to help entrepreneurs build category-defining companies in industries that don’t yet have a playbook.